Serum albumin retains independent prognostic significance in diffuse large B-cell lymphoma in the post-rituximab era

Annals of Hematology

Volumn 93, Issue 8, 2014, Pages 1305-1312

  Dalia, Samir ^a   Chavez, Julio ^a   Little, Bryan ^a   Bello, Celeste ^a   Fisher, Kate ^a   Lee, Ji Hyun ^a   Chervenick, Paul ^a   Sokol, Lubomir ^a   Sotomayor, Eduardo ^a   Shah, Bijal ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Albumin; DLBCL; Non Hodgkin lymphoma; Prognosis; Risk factors

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; SERUM ALBUMIN; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; FEMALE; HUMAN; LARGE CELL LYMPHOMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RISK FACTOR; SURVIVAL TIME;

ADULT; AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HIV SERONEGATIVITY; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHOCYTE COUNT; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; PREDNISONE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK; SERUM ALBUMIN; TUMOR MARKERS, BIOLOGICAL; VINCRISTINE; YOUNG ADULT;

EID: 84904739894     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-014-2031-2     Document Type: Article

References (39)

1. Cultrera JL, Dalia SM (2012) Diffuse large B-cell lymphoma: current strategies and future directions. Cancer Control 19(3):204-213
2. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) N Engl J Med 329(14):987-994. doi :10.1056/nejm199309303291402
3. Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, Morel P, Van Den Neste E, Salles G, Gaulard P, Reyes F, Lederlin P, Gisselbrecht C (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346(4):235 - 242. doi:10.1056/NEJMoa011795
4. Coiffier B, Thieblemont C, Van Den Neste E, Lepeu G, Plantier I, Castaigne S, Lefort S, Marit G, Macro M, Sebban C, Belhadj K, Bordessoule D, Ferme C, Tilly H (2010) Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte. Blood 116(12):2040-2045. doi:10.1182/blood-2010-03-276246
5. Sehn LH, Berry B, Chhanabhai M, Fitzgerald C, Gill K, Hoskins P, Klasa R, Savage KJ, Shenkier T, Sutherland J, Gascoyne RD, Connors JM (2007) The revised International Prognostic Index (RIPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood 109(5):1857-1861. doi:10.1182/blood-2006-08-038257 (Pubitemid 46348180)
6. Peyrade F, Jardin F, Thieblemont C, Thyss A, Emile JF, Castaigne S, Coiffier B, Haioun C, Bologna S, Fitoussi O, Lepeu G, Fruchart C, Bordessoule D, Blanc M, Delarue R, Janvier M, Salles B, Andre M, Fournier M, Gaulard P, Tilly H (2011) Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial. Lancet Oncol 12(5):460-468. doi:10.1016/s1470- 2045(11)70069-9
7. Pavlidis AN, Kalef-Ezra J, Bourantas LC, Lambrou A, Mavridis A (1993) Serum tumor markers in non-Hodgkin's lymphomas and chronic lymphocytic leukemia. Int J Biol Markers 8(1):14-20 (Pubitemid 23126514)
8. Suzumiya J, Ohshima K, Kanda M, Kato A, Shuuda K, Kimura N, Tamura K, Kikuchi M (1998) Intravascular large cell lymphoma associated with hypoalbuminemia. Leuk Lymphoma 32(1-2):179-182. doi:10.3109/10428199809059259 (Pubitemid 29086396)
9. Coiffier B, Lepage E (1993) Prognostic factors in large-cell lymphomas. Leuk Lymphoma 10(Suppl):57 - 60. doi:10.3109/10428199309149113
10. Horn H, Ziepert M, Becher C, Barth TF, Bernd HW, Feller AC, Klapper W, Hummel M, Stein H, Hansmann ML, Schmelter C, Moller P, Cogliatti S, Pfreundschuh M, Schmitz N, Trumper L, Siebert R, Loeffler M, Rosenwald A, Ott G (2013) MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma. Blood 121(12):2253-2263. doi:10.1182/blood-2012-06-435842
11. Visco C, Li Y, Xu-Monette ZY, Miranda RN, Green TM, Tzankov A, Wen W, Liu WM, Kahl BS, d ' Amore ES, Montes-Moreno S, Dybkaer K, Chiu A, Tam W, Orazi A, Zu Y, Bhagat G, Winter JN, Wang HY, O'Neill S, Dunphy CH, Hsi ED, Zhao XF, Go RS, Choi WW, Zhou F, Czader M, Tong J, Zhao X, van Krieken JH, Huang Q, Ai W, Etzell J, Ponzoni M, Ferreri AJ, Piris MA, Moller MB, Bueso-Ramos CE, Medeiros LJ, Wu L, Young KH (2012) Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Leukemia 26(9):2103-2113. doi:10.1038/leu.2012.83
12. Sehn LH (2012) Paramount prognostic factors that guide therapeutic strategies in diffuse large B-cell lymphoma. Hematol Am Soc Hematol Educ Prog 2012:402- 409. doi:10.1182/asheducation2012.1.402
13. Perry AM, Mitrovic Z, Chan WC (2012) Biological prognostic markers in diffuse large B-cell lymphoma. Cancer Control 19(3):214-226
14. Ngo L, Hee SW, Lim LC, TaoM, Quek R, Yap SP, Loong EL, Sng I, Hwan-Cheong TL, Ang MK, Ngeow J, Tham CK, Tan MH, Lim ST (2008) Prognostic factors in patients with diffuse large B cell lymphoma: before and after the introduction of rituximab. Leuk Lymphoma 49(3):462-469. doi:10.1080/10428190701809156 (Pubitemid 351298329)
15. Gupta D, Lis CG(2010) Pretreatment serumalbumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J 9:69. doi:10.1186/1475-2891-9-69
16. Goldwasser P, Feldman J (1997) Association of serum albumin and mortality risk. J Clin Epidemiol 50(6):693-703 (Pubitemid 27341819)
17. Finestone HM, Greene-Finestone LS, Wilson ES, Teasell RW(1996) Prolonged length of stay and reduced functional improvement rate in malnourished stroke rehabilitation patients. Arch Phys Med Rehabil 77(4):340-345 (Pubitemid 26111748)
18. Murray MJ, Marsh HM, Wochos DN, Moxness KE, Offord KP, Callaway CW (1988) Nutritional assessment of intensive-care unit patients. Mayo Clin Proc 63(11):1106-1115
19. Chihara D, Oki Y, Ine S, Yamamoto K, Kato H, Taji H, Kagami Y, Yatabe Y, Nakamura S, Morishima Y (2009) Analysis of prognostic factors in peripheral T-cell lymphoma: prognostic value of serum albumin and mediastinal lymphadenopathy. Leuk Lymphoma 50(12):1999-2004. doi:10.3109/10428190903318311
20. Watanabe T, Kinoshita T, Itoh K, Yoshimura K, Ogura M, Kagami Y, YamaguchiM, KurosawaM, TsukasakiK, KasaiM, Tobinai K, Kaba H, Mukai K, Nakamura S, Ohshima K, Hotta T, Shimoyama M (2010) Pretreatment total serum protein is a significant prognostic factor for the outcome of patients with peripheral T/natural killer-cell lymphomas. Leuk Lymphoma 51(5):813-821. doi:10.3109/10428191003721359
21. Zhu YJ, Huang JJ, Xia Y, ZhaoW, JiangWQ, Lin TY, Huang HQ, Li ZM (2011) Primary mediastinal large B-cell lymphoma (PMLBCL) in Chinese patients: clinical characteristics and prognostic factors. Int J Hematol 94(2):178-184. doi:10.1007/s12185-011-0898-4
22. Hasenclever D, Diehl V (1998) A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med 339(21):1506-1514. doi:10.1056/nejm199811193392104
23. Arcaini L, LazzarinoM, Colombo N, Burcheri S, Boveri E, Paulli M, Morra E, Gambacorta M, Cortelazzo S, Tucci A, Ungari M, Ambrosetti A, Menestrina F, Orsucci L, Novero D, Pulsoni A, Frezzato M, Gaidano G, Vallisa D, Minardi V, Tripodo C, Callea V, Baldini L, Merli F, Federico M, Franco V, Iannitto E, Integruppo Italiano L (2006) Splenic marginal zone lymphoma: a prognostic model for clinical use. Blood 107(12):4643-4649. doi:10.1182/blood-2005-11-4659 (Pubitemid 43882609)
24. Kharfan-DabajaMA, Chavez JC, Yu D, ZhuW, Fernandez-Vertiz EI, Perkins J, Shapiro J, Bookout R, Perez L, Fernandez HF, Komrokji RS, Lancet J, Brand L, Field T, Ayala E, JanssenW, List AF, Anasetti C (2011) Severe hypoalbuminemia at day 90 predicts worse nonrelapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome. Biol Blood Marrow Transplant 17(3):384-393. doi:10.1016/j.bbmt.2010.07.011
25. Komrokji RS, Corrales-Yepez M, Kharfan-Dabaja MA, Al Ali NH, Padron E, Rollison DE, Pinilla-Ibarz J, Zhang L, Epling-Burnette PK, Lancet JE, List AF (2012) Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes. Am J Hematol 87(11):1006-1009. doi:10.1002/ajh.23303
26. Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, DreylingM, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25(5):579-586. doi:10.1200/jco.2006.09.2403 (Pubitemid 350002966)
27. Schoenfeld D (1982) Partial residuals for the proportional hazards regression model. Biometrika 69:239-241
28. Perry AM, Cardesa-Salzmann TM, Meyer PN, Colomo L, Smith LM, Fu K, Greiner TC, Delabie J, Gascoyne RD, Rimsza L, Jaffe ES, Ott G, Rosenwald A, Braziel RM, Tubbs R, Cook JR, Staudt LM, Connors JM, Sehn LH, Vose JM, Lopez-Guillermo A, Campo E, Chan WC, Weisenburger DD (2012) A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma. Blood 120(11):2290-2296. doi: 10.1182/blood-2012-05-430389
29. Salles G, de Jong D, Xie W, Rosenwald A, Chhanabhai M, Gaulard P, Klapper W, Calaminici M, Sander B, Thorns C, Campo E, Molina T, Lee A, Pfreundschuh M, Horning S, Lister A, Sehn LH, Raemaekers J, Hagenbeek A, Gascoyne RD, Weller E (2011) Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium. Blood 117(26):7070-7078. doi:10.1182/blood-2011-04-345256
30. Mackintosh JF, Cowan RA, Jones M, Harris M, Deakin DP, Crowther D (1988) Prognostic factors in stage I and II high and intermediate grade non-Hodgkin's lymphoma. Eur J Cancer Clin Oncol 24(10):1617-1622
31. Lin TL, Kuo MC, Shih LY, Dunn P, Wang PN, Wu JH, Tang TC, Chang H, Hung YS (2012) The impact of age, Charlson comorbidity index, and performance status on treatment of elderly patients with diffuse large B cell lymphoma. Ann Hematol 91(9):1383-1391. doi: 10.1007/s00277-012-1463-9
32. Prakash G, Sharma A, Raina V, Kumar L, Sharma MC, Mohanti BK (2012) B cell non-Hodgkin's lymphoma: experience from a tertiary care cancer center. Ann Hematol 91(10):1603-1611. doi:10.1007/s00277-012-1491-5
33. Steward WP, Todd ID, Harris M, Jones JM, Blackledge G, Wagstaff J, Anderson H, Wilkinson PM, Crowther D (1984) A multivariate analysis of factors affecting survival in patients with high-grade histology non-Hodgkin 's lymphoma. Eur J Cancer Clin Oncol 20(7):881-889 (Pubitemid 14086911)
34. Khera R, Jain S, Kumar L, Thulkar S, Vijayraghwan M, Dawar R (2010) Diffuse large B-cell lymphoma: experience from a tertiary care center in North India. Med Oncol 27(2):310-318. doi:10.1007/s12032-009-9211-2
35. Hennig B, Honchel R, Goldblum SE, McClain CJ (1988) Tumor necrosis factor-mediated hypoalbuminemia in rabbits. J Nutr 118(12):1586-1590 (Pubitemid 19042219)
36. Brenner DA, Buck M, Feitelberg SP, Chojkier M (1990) Tumor necrosis factor-alpha inhibits albumin gene expression in a murine model of cachexia. J Clin Invest 85(1):248- 255. doi:10.1172/jci114419
37. McMillan DC, Watson WS, O'Gorman P, Preston T, Scott HR, McArdle CS (2001) Albumin concentrations are primarily determined by the body cellmass and the systemic inflammatory response in cancer patients with weight loss. Nutr Cancer 39(2):210-213. doi: 10.1207/S15327914nc392-8 (Pubitemid 33694037)
38. Ballmer PE, Ochsenbein AF, Schutz-Hofmann S (1994) Transcapillary escape rate of albumin positively correlates with plasma albumin concentration in acute but not in chronic inflammatory disease. Metabolism 43(6):697-705 (Pubitemid 24181195)
39. Aviles A, Yanez J, Lopez T, Garcia EL, Guzman R, Diaz-Maqueo JC (1995) Malnutrition as an adverse prognostic factor in patients with diffuse large cell lymphoma. Arch Med Res 26(1):31-34